Compare Brunswick Corporation (BC) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brunswick Corporation vs Citius Pharmaceuticals Inc — how do they compare? Brunswick Corporation trades at $81.99 (market cap $5.28B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Brunswick Corporation is far larger — about 263.9× Citius Pharmaceuticals Inc's market cap, and Brunswick Corporation pays a 2.16% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| BC | CTXR | |
|---|---|---|
Market Cap | $5.28B | $20.01M |
Sector | Consumer Cyclical | Health |
52-Week High | $89.22 | $1.82 |
52-Week Low | $58.75 | $0.48 |
Enterprise Value | $7.28B | $16.23M |
Dividend Yield | 2.16% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brunswick Corporation
Brunswick Corp is the leader in several recreational sectors. The firm is the leading boat manufacturer, and its brands include Mercury and Mariner outboard engines
Read more on BC →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
